Literature DB >> 9788837

Frontiers in interventional cardiology.

E J Topol1, P W Serruys.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9788837     DOI： 10.1161/01.cir.98.17.1802

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  27 in total

Review 1.  Intervention in coronary artery disease.

Authors:  S Windecker; B Meier
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

2.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

3.  Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: single-center experience with 17,956 revascularization procedures (1993-1997).

Authors:  P Angelini; W K Vaughn; M Zaqqa; J M Wilson; R D Fish
Journal:  Tex Heart Inst J       Date:  2000

Review 4.  Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.

Authors:  L M Khachigian
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

5.  Effects of local cytochalasin D delivery on smooth muscle cell migration and on collar-induced intimal hyperplasia in the rabbit carotid artery.

Authors:  R H Bruijns; H Bult
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 6.  Gene therapy for coronary restenosis: is the enthusiasm justified?

Authors:  M O'Sullivan; M R Bennett
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

7.  New advances in the management of acute coronary syndromes.

Authors:  P W Armstrong
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

Review 8.  ABC of interventional cardiology: percutaneous coronary intervention. I: history and development.

Authors:  Ever D Grech
Journal:  BMJ       Date:  2003-05-17

Review 9.  [Rheological determinants of end-organ damage].

Authors:  M Leschke; W Klimek; F Jung
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

Review 10.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.